Cargando…
Role of macrolide therapy in chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability worldwide. The Global Burden of Disease study has concluded that COPD will become the third leading cause of death worldwide by 2020, and will increase its ranking of disability-adjusted life years lost from 12th...
Autores principales: | Martinez, Fernando J, Curtis, Jeffrey L, Albert, Richard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629987/ https://www.ncbi.nlm.nih.gov/pubmed/18990961 |
Ejemplares similares
-
Macrolides: a promising pharmacologic therapy for chronic obstructive
pulmonary disease
por: Qiu, Shilin, et al.
Publicado: (2016) -
Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019) -
Current status and inspiration on macrolides in the treatment of chronic obstructive pulmonary disease
por: Qiu, Shi-lin, et al.
Publicado: (2015) -
Macrolide Therapy in Chronic Inflammatory Diseases
por: Kwiatkowska, Brygida, et al.
Publicado: (2012) -
Long-term macrolide therapy for chronic obstructive pulmonary disease: a population-based time series analysis
por: Yan, Marie, et al.
Publicado: (2021)